BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2244209)

  • 1. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence.
    Rauscher FJ; Morris JF; Tournay OE; Cook DM; Curran T
    Science; 1990 Nov; 250(4985):1259-62. PubMed ID: 2244209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.
    Nakagama H; Heinrich G; Pelletier J; Housman DE
    Mol Cell Biol; 1995 Mar; 15(3):1489-98. PubMed ID: 7862142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing of Wilms' tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes.
    Laity JH; Chung J; Dyson HJ; Wright PE
    Biochemistry; 2000 May; 39(18):5341-8. PubMed ID: 10820004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor.
    Zipfel PF; Decker EL; Holst C; Skerka C
    Biochim Biophys Acta; 1997 Nov; 1354(2):134-44. PubMed ID: 9396630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation.
    Blok LJ; Grossmann ME; Perry JE; Tindall DJ
    Mol Endocrinol; 1995 Nov; 9(11):1610-20. PubMed ID: 8584037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.
    Morris JF; Madden SL; Tournay OE; Cook DM; Sukhatme VP; Rauscher FJ
    Oncogene; 1991 Dec; 6(12):2339-48. PubMed ID: 1662794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
    Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
    Hamilton TB; Barilla KC; Romaniuk PJ
    Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear localization signal of NGFI-A is located within the zinc finger DNA binding domain.
    Matheny C; Day ML; Milbrandt J
    J Biol Chem; 1994 Mar; 269(11):8176-81. PubMed ID: 8132543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the DNA binding characteristics of the related zinc finger proteins WT1 and EGR1.
    Hamilton TB; Borel F; Romaniuk PJ
    Biochemistry; 1998 Feb; 37(7):2051-8. PubMed ID: 9485332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
    Skerka C; Decker EL; Zipfel PF
    Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1.
    Zhai G; Iskandar M; Barilla K; Romaniuk PJ
    Biochemistry; 2001 Feb; 40(7):2032-40. PubMed ID: 11329270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. +P5 (D1S3309E), a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21-->22.
    Negus K; Holmes GH; Wicking C; Wainwright BJ; Little MH
    Cytogenet Cell Genet; 1996; 72(4):306-9. PubMed ID: 8641136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of major and minor groove DNA interactions by the zinc fingers of Xenopus transcription factor IIIA.
    McBryant SJ; Gedulin B; Clemens KR; Wright PE; Gottesfeld JM
    Nucleic Acids Res; 1996 Jul; 24(13):2567-74. PubMed ID: 8692697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
    Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
    Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.
    Bardeesy N; Pelletier J
    Nucleic Acids Res; 1998 Apr; 26(7):1784-92. PubMed ID: 9512553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.